CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 28 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $4,030,000 | +566.1% | 500,000 | +376.2% | 1.11% | +224.9% |
| Q2 2017 | $605,000 | +24.7% | 105,000 | -58.0% | 0.34% | +79.1% |
| Q3 2015 | $485,000 | -24.9% | 250,000 | +4.2% | 0.19% | -6.4% |
| Q2 2015 | $646,000 | -81.3% | 240,000 | -52.0% | 0.20% | -86.0% |
| Q1 2015 | $3,460,000 | +181.5% | 500,000 | +300.0% | 1.46% | +144.9% |
| Q4 2014 | $1,229,000 | +43.7% | 125,000 | 0.0% | 0.59% | +30.0% |
| Q3 2014 | $855,000 | – | 125,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,254,502 | $20,741,000 | 14.54% |
| Versant Venture Management, LLC | 1,048,601 | $9,647,127,000 | 10.15% |
| Abingworth LLP | 1,147,077 | $10,553,000 | 7.65% |
| Omega Fund Management, LLC | 551,477 | $5,074,000 | 3.67% |
| Opaleye Management Inc. | 665,000 | $6,118,000 | 1.96% |
| DAFNA Capital Management LLC | 361,164 | $3,323,000 | 1.79% |
| Boxer Capital, LLC | 1,012,986 | $9,319,000 | 1.70% |
| Foresite Capital Management III, LLC | 600,000 | $5,520,000 | 1.55% |
| NEXTHERA CAPITAL LP | 536,568 | $4,936,000 | 0.91% |
| Perceptive Advisors | 2,685,882 | $24,710,000 | 0.82% |